Injectable Drug Delivery Market to Rise at a CAGR of 12.9% by 2027

Posted by saurabh on May 16th, 2022

The global injectable drug delivery market is anticipated to rise at a CAGR of 12.9% to reach USD 1,251.28 billion by the end of 2027 owing to the increasing prevalence of various diseases and the need for easy drug delivery to various target sites. Injectable drug delivery helps to provide effective drug delivery experience with speedy delivery. It is also considered as one of the most efficient routes of administration, thus ensuring improved patient experience. As per a report by Fortune Business Insights, titled, “Injectable Drug Delivery Market Size, Share & COVID-19 Impact Analysis, By Device Type (Conventional Injectable, Pre-filled syringes, Auto- injectors, Pen Injectors, and Wearable), By Product Type (Freeze-dried Products, Injectable Sterile Products), By End User (Hospitals, Homecare Settings, Clinics, and Others), and Regional Forecast, 2020-2027,” the value of this market was USD 483.45 billion in the year 2019 and the forecast period is set between 2020 and 2027.

Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/injectable-drug-delivery-market-101044

What is the Scope of this market?

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

Geographical Analysis:

•          North America (The U.S. and Canada)
•          Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
•          Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
•          Latin America (Brazil, Mexico, and the Rest of Latin America)
•          The Middle East & Africa (South Africa, GCC, and the Rest of the Middle East & Africa)

The current COVID-19 pandemic has left us in a world of outcry and devastation. The healthcare sector is overburdened with more number of patients than the number of beds available. Most businesses are at a temporary halt while some others are going an extra mile to generate enough revenue so as to make the midnight oil burn. The coronavirus pandemic has affected the world economy at large and we are all hoping for a remedy – an antidote to fight this disease will soon be invented so that we can go back to our normal life.

Fortune Business Insights is offering special analytical reports on different markets that are impacted by the COVID-19 pandemic. These reports will help investors study the complete evaluations of the market, and current situation, and accordingly chalk out plans to gain maximum revenue in the coming years.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/injectable-drug-delivery-market-101044